# WEIBO Corp: Form 20-F for the period ended Dec 31, 2024

- Company: [WEIBO Corp](/companies/wb.md) (CIK 1595761)
- Form: 20-F
- Filed: 2025-04-15
- Accepted by EDGAR: Apr 15, 2025, 06:04 ET
- Period: 2024-12-31
- Accession: 0001410578-25-000730
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1595761/000141057825000730/wb-20241231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1595761/000141057825000730/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $1.75bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $369.5m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $308.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | $494.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $105.4m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $110.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | $300.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $1.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 265,241 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $639.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $61.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $1.89bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $3.49bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $6.50bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $968.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $2.93bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $2.19bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2024-12-31 | $3.48bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1595761/000141057825000730/wb-20241231x20f.htm

Filed Apr 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001410578-25-000730. Last ingested by Listed: Oct 28, 2026, 07:35 ET. No prices; not investment advice.
